Latest Capital Markets News

Banco Santander has launched A$550 million of fixed rate senior notes due in 2031, exclusively aimed at professional and eligible counterparties under MiFID II regulations. The notes will be listed on the ASX and carry investment-grade ratings.

Banco Santander has launched a A$450 million tranche of floating rate senior notes due in 2031, targeting exclusively professional and eligible counterparties under MiFID II regulations. The notes offer a quarterly interest rate tied to the 3-month BBSW plus a margin of 0.97%.

La Trobe Financial Capital Markets Trust 2022-1 has completed the redemption of its Class A1L and A2 Notes, leading to their suspension and removal from the ASX Official List.

ION Video Ltd’s recent General Meeting saw overwhelming shareholder approval for crucial resolutions, including a securities consolidation and advisor options ratification.

Cyprium Metals has secured $80 million in funding and advanced key infrastructure works to restart copper production at its Nifty Copper Complex, targeting first cathode output by mid-2026.

Vitasora Health has completed an A$11 million capital raise, including a cornerstone investment, bolstering its balance sheet to support ambitious growth in the US healthcare market. The company targets cash flow breakeven by the end of FY2026 amid expanding patient programs and new partnerships.

Ausgold Limited has delivered an updated Definitive Feasibility Study for its Katanning Gold Project, revealing increased gold production and enhanced financial returns, supported by a $90 million capital raise to accelerate development.

4DMedical Limited has raised $150 million through a well-supported institutional placement to accelerate the commercialisation of its innovative lung imaging product CT – VQ™ in the US market. The capital raise comes with minimal dilution and increased insider confidence.

MetalsTech Limited is progressing its Pre-Feasibility Study for the Sturec Gold Mine in Slovakia, targeting completion in the first half of 2026, alongside key board appointments aimed at driving the project forward.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Astral Resources has reported significant progress in its Mandilla Gold Project, underpinned by robust drilling outcomes and a $65 million capital raise to fund development. The company is on track for a Final Investment Decision in September 2026, aiming for first gold production by the end of 2027.

Janus Electric has appointed Ben Hutt as CEO and Managing Director, aiming to fast-track its innovative exchangeable battery systems for heavy transport. Hutt’s extensive energy transition and capital markets experience positions the company for its next growth phase.